Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma. Jefferson Antonio B, Patino DG, Cossio-Giraldo YE. J Asthma 2021 Sep 22:1-8. doi: 10.1080/02770903.2021.1984527.

Read + Share

Amedeo Smart

Independent Medical Education

Jefferson Antonio B, Patino DG, Cossio-Giraldo YE. Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma. J Asthma 2021 Sep 22:1-8. doi: 10.1080/02770903.2021.1984527.
PMID: 34551659